Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 121
1958 213
1959 110
1960 2
1962 2
1963 2
1964 3
1965 48
1966 79
1967 88
1968 107
1969 143
1970 162
1971 155
1972 115
1973 108
1974 105
1975 88
1976 92
1977 79
1978 59
1979 74
1980 67
1981 47
1982 55
1983 59
1984 67
1985 60
1986 78
1987 44
1988 91
1989 79
1990 86
1991 102
1992 117
1993 104
1994 116
1995 212
1996 361
1997 608
1998 699
1999 764
2000 754
2001 817
2002 1095
2003 1118
2004 1319
2005 1498
2006 1774
2007 2196
2008 2221
2009 2525
2010 2642
2011 2684
2012 3046
2013 3228
2014 3569
2015 3513
2016 3590
2017 3687
2018 3460
2019 1769
2020 47
Text availability
Article attribute
Article type
Publication date

Search Results

47,436 results
Results by year
Filters applied: . Clear all
Page 1
An update on the safety of SGLT2 inhibitors.
Scheen AJ. Scheen AJ. Expert Opin Drug Saf. 2019 Apr;18(4):295-311. doi: 10.1080/14740338.2019.1602116. Epub 2019 Apr 16. Expert Opin Drug Saf. 2019. PMID: 30933547 Review.
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.
Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N. Tentolouris A, et al. Int J Environ Res Public Health. 2019 Aug 17;16(16):2965. doi: 10.3390/ijerph16162965. Int J Environ Res Public Health. 2019. PMID: 31426529 Free PMC article. Review.
Non-insulin pharmacological therapies for treating type 1 diabetes.
Frandsen CS, Dejgaard TF, Madsbad S, Holst JJ. Frandsen CS, et al. Expert Opin Pharmacother. 2018 Jun;19(9):947-960. doi: 10.1080/14656566.2018.1483339. Expert Opin Pharmacother. 2018. PMID: 29991320 Review.
The safety of gliptins : updated data in 2018.
Scheen AJ. Scheen AJ. Expert Opin Drug Saf. 2018 Apr;17(4):387-405. doi: 10.1080/14740338.2018.1444027. Epub 2018 Mar 3. Expert Opin Drug Saf. 2018. PMID: 29468916 Review.
Drugs for type 2 diabetes.
Med Lett Drugs Ther. 2019 Nov 4;61(1584):169-178. Med Lett Drugs Ther. 2019. PMID: 31770362 Review. No abstract available.
Ertugliflozin for the treatment of type 2 diabetes.
Sharma R, Razdan K, Kuhad A, Kuhad A. Sharma R, et al. Drugs Today (Barc). 2019 Mar;55(3):167-175. doi: 10.1358/dot.2019.55.3.2904972. Drugs Today (Barc). 2019. PMID: 30938372 Review.
47,436 results
Jump to page
Feedback